The Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection in Renal Transplant Recipients

The treatment for chronic active antibody-mediated rejection (CAMR) remains controversial. We investigated the efficacy of rituximab (RTX) and intravenous immunoglobulin (IVIg) for CAMR. Eighteen patients with CAMR were treated with RTX (375 mg/m(2)) and IVIg (0.4 g/kg) for 4 days. The efficacy of R...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: An, Gun Hee, Yun, Jintak, Hong, Yu Ah, Khvan, Marina, Chung, Byung Ha, Choi, Bum Soon, Park, Cheol Whee, Choi, Yeong Jin, Kim, Yong-Soo, Yang, Chul Woo
פורמט: Artigo
שפה:Inglês
יצא לאור: Hindawi Publishing Corporation 2014
נושאים:
Clinical Study
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3987969/
https://ncbi.nlm.nih.gov/pubmed/24741626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/828732
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים